Previously, several clinical and pathological parameters such as prostate-specific antigen (PSA), PSA density (PSAD), positive core percentage, and maximum percentage of cancer per core were reported as predictors of pathological upgrading [3]. This evidence concerns the gene KLK3 and cancer.